Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY – Get Free Report) saw strong trading volume on Thursday . Approximately 205,423 shares were traded during trading, an increase of 89% from the previous session’s volume of 108,823 shares.The stock last traded at $14.32 and had previously closed at $14.58.
Wall Street Analyst Weigh In
Separately, Zacks Research raised Sonic Healthcare to a “hold” rating in a research report on Friday, April 17th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Reduce”.
View Our Latest Stock Report on SKHHY
Sonic Healthcare Stock Performance
Sonic Healthcare Company Profile
Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.
Read More
- Five stocks we like better than Sonic Healthcare
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
- Otis Took Another Guidance Cut—But the Story Isn’t Over
- Is Buying a Launch Company AST SpaceMobile’s Next Vertical Integration Move?
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
